Mainz Biomed N.V. MYNZ 深 沪
交易中 09-16 12:08:03 美东时间
0.8441
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.8441
- 总市值 1056.42万
- 52周最高 4.797
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.5476
- 委 比 0.00%
- 总股本 1251.53万
- 历史最高 1200.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.5476
- 每 手 1
- 风险率 0.29%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Quantum Cyber jumps on $2M purchase orders
Quantum Cyber (QUCY) said its wholly owned subsidiary, Quantum Drones Corp., has received purchase orders worth ~$2.09M. These orders were received as part of the company’s acquisition of a 50,000 squ...
07-16 19:43
Quantum Cyber Rejects Short-Seller Claims as it Details Drone Production Plans
Quantum Cyber NV (NASDAQ:QUCY) on Monday responded to a recently published short-seller report, arguing that it contains misleading claims about the company’s capital structure, business strategy and technology relationships. • What’s going on with QUCY shares? The AI-supported defense platform comp...
07-07 01:24
Quantum Cyber Addresses Short Seller Biased Report
Quantum Cyber N.V. has responded to a short-seller report, claiming it contains misleading information about the company's capital structure, business strategy, and technology relationships. The company states that its capital structure is fully disclosed in SEC filings and that the "hidden" share count referenced in the report is inaccurate. It also emphasizes that its CEO, David Lazar, has invested $6 million into the company, aligning his inte...
07-06 11:00
Quantum Cyber forms U.S. defense subsidiary for drone programs
Quantum Cyber N.V. (QUCY) said on Monday it formed Quantum Drones Corporation, a wholly owned Nevada-based subsidiary focused on pursuing U.S. government opportunities in autonomous drone warfare, cou...
05-18 22:36
Mainz Biomed changes ticker symbol to "QUCY"
Mainz Biomed (QUCY), doing business as Quantum Cyber, has officially changed its ticker symbol to "QUCY" on the Nasdaq Capital Market. Further, the company’s name will change to Quantum Cyber N.V., ef...
03-13 19:55
Mainz Biomed Appoints Robert Liscouski As Chairman Of Its Board Of Directors; Co Plans To Change Its Name To Quantum Cyber And Nasdaq Ticker Symbol To QUCY, Effective March 12
Mainz Biomed N.V. (NASDAQ:MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced that Robert P. Liscouski has been appointed Chairman of its Board of Directors.
03-11 19:34
Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors
Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company, announced the appointment of Robert P. Liscouski as Chairman of its Board of Directors and planned to change its name to Quantum Cyber and its Nasdaq ticker symbol to QUCY starting March 12, 2026. The changes will become official at an extraordinary general meeting in April 2026. Liscouski, a seasoned executive with expertise in cybersecurity, AI, and critical infrastructu...
03-11 11:30
Mainz Biomed To Present Poster Titled BLOOD-BASED MRNA SIGNATURE FOR DETECTION OF PANCREATIC DUCTAL ADENOCARCINOMA AND DISCRIMINATION OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS At Digestive Disease Week In Chicago
Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, is excited to announce its participation in the renowned Digestive Disease Week (DDW) 2026 in
02-24 20:44
Mainz Biomed Raises $6M Private Placement To Fund Operations And Shift Focus To Pancreatic Cancer Screening
Mainz Biomed N.V. (NASDAQ:MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, announced a series of strategic transactions designed to strengthen its liquidity position,
02-17 20:35
Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update
Mainz Biomed secures $6M private placement to focus on pancreatic cancer detection in the U.S., sell colorectal cancer assets, and wind down German operations, aiming to stabilize and grow its业务 while exploring strategic alternatives.
02-17 12:30
